Analyses of clinical features for responders on imatinib mesylate to Chinese patients with advanced gastrointestinal stromal tumor as first-line treatment: multi-center, eight years followed-up outcomeLIU Xiufeng, LI Jian, LI Yong, ZHOU Yongjian, SHEN Lin, LU Huishan, QIN Shukui97-105
Effect of protein kinase D inhibitor SD-208 on the proliferation and apoptosis of non-small cell lung cancer cellsWANG Sujia, HU Min106-110
Effect of cisplatin on the expression of PD-L1 of lung squamous cell cancerQIN Aiying, REN Tiejun111-116
Experimental study of toxoflavin on human non-small cell lung cancer cells A549MING Hao, ZONG Yun, XIE Quanqin, CHEN Lujun, XU Bin, LI Chong, JIANG Jingting117-120
An experimental study on RRM1 silencing increases the sensitivity of gastric cancer AGS cells to oxaliplatinGUO Difeng, YANG Jiyuan, CAI Zhiqiang, LIN Chenshi, WANG Meng121-125
Effect of β-carboline alkaloid on proliferation, apoptosis and expression levels of PTEN/Akt in human gastric cancer SGC-7901 cellsZENG Fanye, FAN Yuxiang, ZHANG Hongliang126-129
Effect of BML-210 on the proliferation, apoptosis and cell cycle of glioma U251 cellsWANG Bin, HAN Zhiqiang, HOU Lijun130-134
The efficacy of asparaginase-based chemotherapy combined with radiotherapy among stage ⅠE/ⅡE ENKTL patients and its relationship to asparagine synthetase expressionTANG Lanhua, TANG Youhong, LIU Yiping, LIU Wei, YI Pingyong, ZHONG Meizuo135-141
Level of serum apolipoprotein A-I in patients with advanced non-small cell lung cancer and its clinical significanceSHI Hui, SUN Qinying, HAN Yiping, DONG Yuchao, BAI Chong146-151
